Table of Contents
 
  UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
  FORM 10-Q
 þ

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended September 30, 2010o

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from __________ to __________
  Commission file number:  001-31669
  SUNRIDGE INTERNATIONAL, INC.
 (Exact name of registrant as specified in its charter)
  Nevada

98-0348905(State or other jurisdiction of

(IRS Employer Identification No.)incorporation or organization)
  16857 E. Saguaro Blvd.
 Fountain Hills, Arizona 85268
 (Address of principal executive offices)
  (480) 837-6165
 (Registrant’s telephone number, including area code)
   Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  þNo o
  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  oNo þ  Not applicable.
 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.  (Check one):
  Large accelerated filer    o
Accelerated filer    oNon-accelerated filer    o
Small reporting company    þ
 Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).  Yes  oNo þ
 As of November 11, 2010, 45,029,816 shares of the issuer’s common stock were outstanding.


Table of Contents


SUNRIDGE INTERNATIONAL, INC.




Table of Contents






PageForward-Looking Statements
3PART I.  FINANCIAL INFORMATIONItem 1.
Financial Statements
4Consolidated Balance Sheets as of September 30, 2010 (Unaudited) and June 30, 2010
4Unaudited Consolidated Statements of Operations for the Three Months ended September 30, 2010 and 2009
5Unaudited Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the Three Months ended September 30, 2010
6Unaudited Consolidated Statements of Cash Flows for the Three Months ended September 30, 2010 and 2009
7Notes to Unaudited Consolidated Financial Statements
8Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
16Item 3.
Quantitative and Qualitative Disclosures About Market Risk
18Item 4.
Controls and Procedures
19PART II.  OTHER INFORMATIONItem 1.
Legal Proceedings
20Item 1A.
Risk Factors
20Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
20Item 3.
Defaults Upon Senior Securities
21Item 4.
(Removed and Reserved)
21Item 5.
Other Information
21Item 6.
Exhibits
21Signatures
22
  2
 Table of Contents




SUNRIDGE INTERNATIONAL, INC.
  FORWARD-LOOKING STATEMENTS
  This Quarterly Report on Form 10-Q (“Quarterly Report”) contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and should be read in conjunction with the Financial Statements of SunRidge International, Inc. (the “Company” or “SunRidge”).  Such statements are not historical facts and reflect our current views regarding matters such as operations and financial performance. In general, forward-looking statements are identified by such words or phrases as “expects,” “anticipates,” “believes,” “could,” “approximates,” “estimates,” “may,” “intends,” “predicts,” “projects,” “plans,” or “will,” or the negative of those words or other terminology. These statements are not guarantees of future performance and involve certain  known and unknown inherent risks, uncertainties and other factors that are difficult to predict; our actual results could differ materially from those expressed in these forward-looking statements.  The cautionary factors, risks and other factors presented should not be construed as exhaustive.   Other risks not presently known to us, or that we currently believe are immaterial, could also adversely affect our business, financial condition or results of operations.
  Each forward-looking statement should be read in context with, and with an understanding of, the various disclosures concerning our business made elsewhere in this Quarterly Report, as well as other public reports filed by us with the United States Securities and Exchange Commission. Readers should not place undue reliance on any forward-looking statement as a prediction of actual results of developments. Except as required by applicable law or regulation, we undertake no obligation to update or revise any forward-looking statement contained in this Quarterly Report.
 3
 Table of Contents


PART I.
FINANCIAL INFORMATION




Item 1.
Financial Statements


SUNRIDGE INTERNATIONAL, INC.
  CONSOLIDATED BALANCE SHEETS
 September 30, 2010 (Unaudited) and June 30, 2010
 
 9/30/2010


6/30/2010ASSETSCURRENT ASSETSCash and cash equivalents

$
–


$
–Accounts receivable


8,927



8,927Employee advances


–



3,400Prepaid expenses


123,815



179,814Inventory


18,063



20,920Total Current Assets


150,805



213,061Property and equipment, net


2,671



2,871TOTAL ASSETS

$
153,476


$
215,932LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)CURRENT LIABILITIESNotes payable - related parties

$
199,605


$
203,976Notes payable


236,789



293,202Accounts payable


317,964



307,805Cash overdraft


3,661



1,633Accrued interest


54,116



44,902TOTAL LIABILITIES


812,135



851,518COMMITMENTS


–



–STOCKHOLDERS’ EQUITY (DEFICIT)Preferred Stock, $0.001 par value, 50,000,000 sharesauthorized and zero shares outstanding at September 30, 2010and June 30, 2010 respectively


–



–Common Stock - $0.001 par value; 550,000,000 sharesauthorized; 43,589,399 and 42,942,180 shares outstandingat September 30, 2010 and June 30, 2010, respectively


43,589



42,942Additional paid-in capital


13,569,422



13,407,088Accumulated deficit


(14,271,670
)


(14,085,616
)TOTAL STOCKHOLDERS’ EQUITY (DEFICIT)


(658,659
)


(635,586
)TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

$
153,476


$
215,932
  The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.


4
 Table of Contents




SUNRIDGE INTERNATIONAL, INC.
  UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
 For the Three Months Ended September 30, 2010 and 2009
  Three months ended,9/30/2010


9/30/2009PRODUCT REVENUES

$
45,510


$
7,000Cost of Product Revenues


11,953



2,270GROSS PROFIT


33,557



4,730GENERAL & ADMINISTRATIVE EXPENSESEmployee & Consultant Expenses


72,500



1,000Freight


805



14Reorganization Cost


–



176,523Depreciation


200



–Telephone & Utilities


2,560



1,246Office Expenses


2,887



246Insurance


8,915



115Travel & Entertainment


5,973



–Loss on Stock Issuances


30,931



–Legal & Professional Fees


6,204



35,689Rent Expense


14,012



19,360Selling & Marketing Expenses


54,153



–Other General & Operating Expenses


897



949TOTAL GENERAL & ADMINISTRATIVE EXPENSES


200,037



235,142LOSS FROM OPERATIONS


(166,480
)


(230,412
)OTHER INCOME (EXPENSES)Other Income


1,205



–Interest Expense


(20,779
)


(15,166
)TOTAL OTHER INCOME (EXPENSES)


(19,574
)


(15,166
)NET LOSS

$
(186,054
)

$
(245,578
)Basic Loss per Share

$
(0.00
)

$
(0.01
)Weighted Average Shares Outstanding


43,251,810



40,000,000
  The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.


5
 Table of Contents
 SUNRIDGE INTERNATIONAL, INC.
 UNAUDITED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT)
For the Three Months Ended September 30, 2010
 Common Stock


Additional





Stockholders’Paid-in


Accumulated


EquityShares


Par Value


Capital


Deficit


(Deficit)BALANCE AT JULY 1, 2009


40,000,000


$
40,000


$
12,386,970


$
(13,065,719
)

$
(638,749
)Common Stock Issued for Services


1,160,855



1,161



327,875



–



329,036Common Stock Issued for Debt and Interest


1,781,325



1,781



506,084



–



507,865Loss on Stock Issuances


–



–



186,159



–



186,159Net loss for the year ended June 30, 2010


–



–



–



(1,019,897
)


(1,019,897
)BALANCE AT JUNE 30, 2010


42,942,180



42,942



13,407,088



(14,085,616
)


(635,586
)Common Stock Issued for Services


245,161



245



55,055



–



55,300Common Stock Issued for Debt and Interest


302,058



302



59,448



–



59,750Common Stock Issued for Cash


100,000



100



16,900



–



17,000Loss on Stock Issuances


–



–



30,931



–



30,931Net loss for the three months endedSeptember 30, 2010


–



–



–



(186,054
)


(186,054
)BALANCE AT SEPTEMBER 30, 2010


43,589,399


$
43,589


$
13,569,422


$
(14,271,670
)

$
(658,659
)
  The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.
  6
 Table of Contents
  SUNRIDGE INTERNATIONAL, INC.
  UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS
 For the Three Months Ended September 30, 2010 and 2009
  Three months ended,9/30/2010


9/30/2009INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS:OPERATING ACTIVITIES:Net loss

$
(186,054
)

$
(245,578
)Adjustments to reconcile net loss to netcash used by operating activities:Loss on stock issuances


30,931



–Stock and debt issued for interest and services


56,050



–Depreciation


200



200Reorganization costs


–



176,523Changes in Assets and Liabilities:Inventory


2,857



2,140Prepaid expenses


55,999



–Accounts payable


10,159



53,824Accrued interest


9,214



11,764NET CASH USED IN OPERATING ACTIVITIES


(20,644
)


(1,127
)INVESTING ACTIVITIES:Proceeds from reverse merger


–



1,027NET CASH PROVIDED BY INVESTING ACTIVITIES


–



1,027FINANCING ACTIVITIES:Overdraft borrowings (repayment)


2,028



124Repayments on notes payable, related party


(30,917
)


–Repayments on notes payable


(13,600
)


(1,000
)Proceeds from stock issuance


17,000



–Proceeds from borrowings


46,133



2,000NET CASH PROVIDED BY FINANCING ACTIVITIES


20,644



1,124NET CHANGE IN CASH & CASH EQUIVALENTS


–



1,024CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD


–



–CASH AND CASH EQUIVALENTS AT SEPTEMBER 30, 2010 and 2009

$
–


$
1,024Supplemental disclosure of cash flow information:Cash paid during the three months for:Interest

$
10,815


$
3,400Non-cash transactions:Common stock paid for services


55,300



–Common stock paid for interest


750



–Common stock paid for debt


59,000



–Cancellation of debt for repayment of employee advance


3,400



–
 The accompanying condensed notes are an integral part of these unaudited consolidated financial statements.
 7
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
  NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS
  Ophthalmic International, Inc. (“OI”) was incorporated in March 1997 in the state of Nevada. OI had been a wholly owned subsidiary of Coronado Industries, Inc. until January 26, 2007, when OI and its subsidiaries were purchased from Coronado Industries, Inc. for cash and other consideration.
  Tari, Inc. (“Tari”) was incorporated on May 2, 2001 under the laws of the State of Nevada and located in Toronto, Ontario, Canada. The accounting and reporting policies of Tari conformed to accounting principles generally accepted in the United States of America. Tari’s fiscal year end was March 31.
  In September 2009, Tari consummated an Agreement of Share Exchange and Plan of Reorganization (the “Agreement”) with OI. Pursuant to the Agreement, Tari agreed to issue an aggregate of 33,050,000 shares of its restricted common stock to the shareholders of OI in exchange for all the issued and outstanding common stock shares of OI.
  The exchange of shares has been accounted for as a reverse acquisition in the form of a recapitalization with OI as the “accounting acquirer.” Prior to the acquisition, Tari changed its name to SunRidge International, Inc. (hereinafter referred to as “SunRidge” or the “Company”).  Following the acquisition, OI became the wholly owned subsidiary of SunRidge.  SunRidge has adopted a fiscal year end of June 30. Operations after the acquisition have been based in Fountain Hills, Arizona, where the Company manufactures and markets a patented Vacuum Fixation Device and patented suction rings to major medical supply companies and health care providers throughout the world.  As a recapitalization, the accompanying financial statements represent the activity of OI.
  GOING CONCERN
  The Company’s financial statements are presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not made an operating profit since 1996. Further, the Company has a working capital deficit of $ (661,330) and a negative net worth of $ (14,271,670) as of September 30, 2010, which causes a doubt about the ability of the Company to remain a going concern.  As such, the Company’s auditors have expressed a going concern opinion on the financial statements for the fiscal year ended June 30, 2010.
 The financial statements do not include any adjustments to reflect the possible future effects of the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the uncertainty of the Company’s ability to continue as a going concern.
 8
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
  BASIS OF PRESENTATION
  In the opinion of management, the accompanying consolidated financial statements reflect all adjustments (consisting of normal recurring accruals) necessary to present fairly the Company’s financial position as of September 30, 2010 and the results of its operations, changes in stockholders’ deficit, and cash flows for the three months ended September 30, 2010. Although management believes that the disclosures in these consolidated financial statements are adequate to make the information presented not misleading, certain information and footnote disclosures normally included in financial statements that have been prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the rules and regulations of the Securities Exchange Commission.
  The result of operations for the three months ended September 30, 2010, are not necessarily indicative of the results that may be expected for the full fiscal year ending June 30, 2011. The accompanying consolidated financial statements should be read in conjunction with the more detailed consolidated financial statements, and the related footnotes thereto, filed with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2010.
  PRINCIPLES OF CONSOLIDATION
  The consolidated financial statements include the financial position, results of operations, cash flows and changes in stockholders’ equity (deficit) of the Company and its wholly owned subsidiary. All material intercompany transactions, accounts and balances have been eliminated.
  USE OF ESTIMATES IN THE PREPARATION OF FINANCIAL STATEMENTS
  The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include, but are not limited to, collectability of accounts receivable, depreciable lives, realization of net operating losses, and valuation of stock-based transactions.
 9
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
 CASH AND CASH EQUIVALENTS
  Cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less.
  INVENTORIES
  Inventories consist primarily of materials and parts and are stated at the lower of cost, as determined on a first-in, first-out (FIFO) basis, or market.
  ACCOUNTS RECEIVABLE
  The Company follows the allowance method of recognizing uncollectible accounts receivable.  The allowance method recognizes bad debt expense as a percentage of accounts receivable based on a review of the individual accounts outstanding and the Company’s prior history of uncollectible accounts receivable. As of September 30, 2010 and 2009, the Company has not established an allowance for uncollectible accounts receivable. The Company does not record interest income on delinquent receivable balances until it is received. Accounts receivable are generally unsecured.
  PROPERTY AND EQUIPMENT
  Property and equipment are stated at cost. Maintenance and repairs that neither materially add to the value of the property nor appreciably prolong its life are charged to operations as incurred.  Betterments or renewals are capitalized when incurred. Depreciation is provided using accelerated methods over the following useful lives:
  Office furniture & Equipment
5 – 7    YearsMachinery
5 – 7    YearsLeasehold Improvements
5    Years
 10
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
  LONG-LIVED ASSETS
  We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.  Assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
 DEFERRED INCOME TAXES
  Deferred income taxes are provided on an asset and liability method, whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax basis. Deferred tax assets are reduced by a valuation allowance when in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
  LOSS PER SHARE
  Basic loss per share includes no dilution and is computed by dividing loss to common stockholders by the weighted average number of common shares outstanding for the period. The effect of the recapitalization is included in all periods presented.
  Assumed conversion of convertible promissory notes for approximately 150,000 shares at September 30, 2010 has been excluded from the calculation of diluted net loss per common share as its effect would be anti-dilutive (decreases the loss per share).  In addition, as the Company has a net loss available to common stockholders for the quarters ended September 30, 2010 and 2009, the diluted EPS calculation has been excluded from the financial statements.
  FAIR VALUE OF FINANCIAL INSTRUMENTS
  The carrying values of our financial instruments included in current assets and current liabilities approximated their respective fair values at each balance sheet date due to the immediate or short-term maturity of these financial instruments.
 11
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
 RECENT ACCOUNTING PRONOUNCEMENTS
  There have been no recent accounting pronouncements or changes in accounting pronouncements during the three months ended September 30, 2010, that are of significance, or potential significance, to us, except as discussed below.
  In October 2009, the FASB issued guidance on revenue recognition for multiple-deliverable revenue arrangements.  The guidance is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010 and addresses how to separate deliverables and how to measure and allocate arrangement consideration to one or more units of accounting.  The Company has adopted the guidance which did not have a material impact on its financial position and results of operations.
  REVENUE RECOGNITION
  The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, our price is fixed or determinable, and collection is reasonably assured. We recognize revenue on our standard products when title passes to the customer upon shipment. The standard products do not have customer acceptance criteria. The Company has standard rights of return that are accounted for as a warranty provision, although it is deemed immaterial at this time. The Company does not have any price protection agreements or other post shipment obligations. For custom equipment where customer acceptance is part of the sales agreement, revenue will be recognized when the customer has accepted the product. In cases where custom equipment does not have customer acceptance as part of the sales agreement, revenue will be recognized upon shipment, as long as the system meets the specifications as agreed upon with the customer.
  NOTE 3 – DEBT AND DEBT CONVERSION
  For the first quarter ended September 30, 2010, the Company issued $46,133 of promissory notes.  These promissory notes were for a duration of three months with an interest rate of 10% for the term and a default rate of 12%.
 The Company offered the promissory note holders the opportunity to convert their principal and accrued interest into restricted common stock of the Company at various times during the three months ended September 30, 2010.
  Conversions took place between July through September 2010, at the closing bid stock prices between $.20 and $.25 per share, and converted $59,750 of principal and interest.
 12
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
  NOTE 4 – EQUITY
  Preferred Stock
  As of September 30, 2010, our authorized preferred stock is 50,000,000 shares of preferred stock with par value of $0.001 per share. The Company’s Board of Directors has the authority to divide the preferred stock shares into series and to fix the voting powers, designation, preference, and relative participating, option or other special rights, and the qualifications, limitations, or restrictions of the shares of any series so established. The Company has issued no preferred stock shares as of September 30, 2010.
  Common Stock
  In September 2009, Tari, Inc. completed a 5-for-1 forward stock split which brought the shares outstanding of Tari, Inc. from 3,890,000 to 19,450,000. The 5-for-1 forward split has been accounted for retroactively for all periods presented.
  The President of Tari, Inc. contributed 12,500,000 shares of common stock to the Company as part of the exchange of shares with OI.
  In September, 2009, Tari consummated an Agreement of Share Exchange and Plan of Reorganization (the “Agreement”) with OI. Pursuant to the Agreement, Tari agreed to issue an aggregate of 33,050,000 shares of its restricted common stock to all of the shareholders of OI in exchange for all the issued and outstanding common stock of OI.
 
 During the quarter ended September 30, 2010 the following equity transactions took place:
 
 The Company issued 245,161 shares of common stock totaling $55,300 to various consultants and vendors for services performed.
  The Company also issued 302,058 shares of common stock totaling $59,750 to various note holders for payment of principal and interest.
  The Company received $17,000 for the issuance of 100,000 shares of common stock.
 NOTE 5 – LOSS ON STOCK ISSUANCES
  The Company’s promissory note holders were given an incentive to convert the promissory notes to common stock by issuing the stock at a discount from the closing bid trade price. Also, certain consultants were paid in common stock and stock was sold at a discount from the closing bid trade price. As such, the Company recorded a loss on stock issuances of $30,931 on 517,219 shares of stock as of September 30, 2010.
 13
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
 NOTE 6 – RELATED PARTY TRANSACTIONS
  As of September 30, 2010, G. Richard Smith, the Company’s President and a Director, loaned the Company an additional $21,146 and was repaid $29,917.  This debt bears an interest rate of 10% for the term, and 12% per annum thereafter, and is due on demand.  At September 30, 2010, G. Richard Smith was owed $195,605 by the Company.
  NOTE 7 – COMMITMENTS AND CONTINGENCIES
  Operating Leases
  The Company entered into a non-cancelable lease agreement for office space in Fountain Hills, Arizona commencing December 1, 2004, through December 15, 2009. Monthly rental payments were $4,520.  After the lease expired, the Company extended the lease to December 31, 2010, at a monthly rate of $4,520. There is no immediate plan to sign a new rental agreement. As of December 31, 2009, the Company had been delinquent in its rent payments. In order to make up past due payments, the Company issued a promissory note dated January 27, 2010 to convert $70,308.83 in rent and related late and legal fees into a note to pay $17,627 in four quarterly payments for a total principal amount of $70,308.83, including interest at 12% per annum after July 1, 2010. As of September 30, 2010, the Company had not made all the payments required and were in default on the note.
 Indemnification
  The Company has agreed to indemnify its officers and directors for certain events or occurrences that may arise as a result of the officer or director serving in such capacity.  The term of the indemnification period is for the officer’s or director’s lifetime.  The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited.  However, the Company believes the estimated fair value of these indemnification agreements is minimal and has no liabilities recorded for these agreements as of September 30, 2010 and 2009.
  Contingent Liability
  The Company had a consulting agreement with Francesco Aspes whereby a clause stated that the Company would reimburse Mr. Aspes for documented expenses, up to a maximum of 80,000 Euros (or approximately $109,000 USD currently). There is a claim by Mr. Aspes for the maximum amount, however, the Company believes that it is more than reasonably possible that the reimbursement claim is unenforceable. As such, there is no accrued expense related to the potential reimbursement, as no underlying documentation in support of this claim has been received.
 14
 Table of Contents
 
 SUNRIDGE INTERNATIONAL, INC.
  NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
  NOTE 7 – COMMITMENTS AND CONTINGENCIES (Continued)
  Litigation
  On December 16, 2009, the Company’s patent attorneys, Meschkow & Gresham, P.L.C., filed a lawsuit (CV 2009-037698) in the Superior Court for Maricopa County, Arizona against the Company and Mr. Richard Smith for breach of contract in the failure to pay for legal services in the amount of $12,063 plus costs and legal fees. The Company’s answer to the complaint admitted that legal services had been provided but claimed no knowledge of the value of those services. This case was transferred to arbitration and an award was rendered in the amount of $8,064 against G. Richard Smith, our President and Director, his wife, Karen Smith and the Ophthalmic International, Inc., our wholly owned subsidiary, plus court costs of $453 and attorney fees of $1,500.  This arbitration award has not been filed with the Clerk of the Court to proceed to judgment yet.
  In the fourth quarter of fiscal year ended June 30, 2010, Charles E. Brokup filed a lawsuit (CV 2010-054295) in Superior Court for Maricopa County, Arizona against Ophthalmic International, Inc. and Mr. G. Richard Smith for breach of promise to pay $10,000 principal on a promissory note and $1,000 per month in interest. The Company’s answer to the complaint admitted that the principal amount of $10,000 was owed but denies that more than legal interest is owed after the first month expressly stated interest of $1,000.
  During the first quarter of fiscal year 2011, Francesco Aspes, our former European marketing consultant, filed a lawsuit (CV 2010-028530) in the Superior Court for Maricopa County, Arizona against the Company for failure to pay him $180,000 of employee wages earned previously plus 80,000 Euros of expenses incurred as an employee of the Company. Our answer to this complaint has not yet been filed.  The $180,000 has been accrued in the accompanying financial statements, but, as discussed above, the claim for 80,000 Euros in expense reimbursement is being disputed.
  NOTE 8 – SUBSEQUENT EVENTS
  Between October 1, 2010 and November 11, 2010, the Company issued the following restricted common stock: (i) 60,417 shares for $8,500 of services; (ii) 130,000 shares in conversion of $13,000 of debt and accrued interest; (iii) 200,000 shares for $22,000 of public relations services; (iv) 790,909 shares for $34,000 cash; and (v) 259,091 shares for $27,500 of consulting services. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.
 15
 Table of Contents


SUNRIDGE INTERNATIONAL, INC.
 Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.


Overview
  The following is a discussion of the financial condition of the Company as of September 30, 2010 and June 30, 2010, and results of operations of the Company as of and for the periods ended September 30, 2010 and 2009.  This discussion should be read in conjunction with the Financial Statements of the Company and the related notes included in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on November 15, 2010.
 On September 5, 2009, we entered into an Agreement of Share Exchange and Plan of Reorganization (the “Share Exchange Agreement”) and consummated a share exchange (the “Share Exchange”) with Ophthalmic International, Inc. (“OI”), a Nevada corporation.  The closing date of the transaction was September 29, 2009 (the “Closing Date”) and resulted in the acquisition of OI (the “Acquisition”).  Pursuant to the terms of the Share Exchange Agreement, we acquired all of the outstanding capital stock of OI from the five OI shareholders, and the OI shareholders transferred and contributed all of their share interests in OI to us .  In exchange, we issued to the OI shareholders 33,050,000 shares, or approximately 82.6% of our common stock.  On the Closing Date, OI became our wholly owned subsidiary.
 Ophthalmic International, Inc.
 OI was founded in 1997 and until January 2007, was a subsidiary of Coronado Industries, Inc., a publicly traded company.  In January 2007, OI was acquired by G. Richard Smith, OI’s President and majority shareholder and former Chairman, Director and principal shareholder of Coronado Industries, Inc.  Since January 2007, OI has operated as a private company.  At one time OI attempted a merger with a public company, but the terms were unsatisfactory so the deal was not consummated and OI remained private.
 Since 1997, Ophthalmic International, Inc. has manufactured and marketed a fixation device with a patented designed suction ring that treats Open Angle and Pigmentary glaucoma.
  In the United States, glaucoma is the second leading cause of blindness affecting approximately 3,000,000 persons. Of those, about 60,000 are legally blind. If detected and treated early, glaucoma need not cause blindness or even severe vision loss. While there is no cure for glaucoma, we believe that our patented device and process provide an effective treatment for afflicted persons and that a significant global market for our patented process, equipment and rings currently exists. OI has not yet received FDA approval for sale of its products in the United States and at this time it appears OI’s sales in Europe and Canada will be negatively impacted until such FDA approval is obtained.
 16
 Table of Contents
 SUNRIDGE INTERNATIONAL, INC.
 Glaucoma may have many forms which cause or present a feature of progressive damage to the optic nerve due to increased pressure within the eyeball. As the optic nerve deteriorates, blind spots and patterns develop. If left untreated, the result may be total blindness. The space between the lens and the cornea in the eye is filled with a fluid called the aqueous humor. This fluid circulates from behind the colored portion of the eye (the iris) through the opening at the center of the eye (pupil) and into the space between the iris and cornea. The aqueous humor is produced constantly, so it must be drained constantly. The drain is at the point where the iris and cornea meet, known as the drainage angle, which directs fluid into a channel (Schlemm’s canal) that then leads it to a system of small veins outside the eye. When the drainage angle does not function properly, the fluid cannot drain and pressure builds up within the eye. Pressure also is exerted on another fluid in the eye, the vitreous humor behind the lens, which in turn presses on the retina. This pressure affects the fibers of the optic nerve, slowly damaging them. The result over time is a loss of vision.
 Results of Operations
 Three Months Ended September 30, 2010
 
 The Company’s revenues in the quarter ended September 30, 2010 increased by 550.1% ($38,510) over the quarter ended September 30, 2009, but total expenses far exceeded our revenues in the quarter.  The Gross Profit increase resulted from the commencement of sales in China and a higher per unit price charged to customers. The Gross Profit on our sales increased in the quarter ended September 30, 2010 to 73.7% from 67.6% in the September 30, 2009 quarter.
  Our loss from operations decreased by 27.5% ($63,392) in the first quarter of our 2011 fiscal year in comparison to first quarter of our 2010 fiscal year because of our increased sales and decreased general and administrative expenses. Our total general and administrative expenses decreased by 14.9% ($35,105) in the quarter ended September 30, 2010 in comparison to the quarter ended September 30, 2009, as a result primarily of the one-time Reorganization Costs of $176,523 being accrued in the prior year.  The Reorganization Costs were incurred during the quarter ended September 30, 2009 as a result of the Company's acquisition of Ophthalmic International, Inc. in October 2009.During the current year's quarter, our greatest expenses were the Loss on Stock Issuance, our increased Employee and Consultant Expenses, and our increased Selling and Marketing Expenses. The Loss on Stock Issuance of $30,931 occurred during the first quarter of the 2011 fiscal year as a result of issuing restricted stock at a value less than market value of free trading stock. Our Employee and Consultants Expenses increased by $71,500 in the first quarter of fiscal 2011 over the fiscal 2010 first quarter as a result of having minimal such expenses in the fiscal 2010 quarter and the use of an investor relations consultant during the first quarter of fiscal 2011. Our Employee and Consultant Expenses will likely increase as we expand shipment of our products to China, Europe and the Caribbean in the future, assuming we can obtain sufficient working capital. We will likely commence paying our officers and Directors compensation some time in the future. Our Selling and Marketing Expenses increased during the first quarter of our 2011 fiscal year over the first quarter of our 2010 fiscal year as a result of having no such expenses in the first quarter of our 2010 fiscal year and our increased marketing activities in India and the Middle East in the first quarter of our 2011 fiscal year. Our Selling and Marketing Expenses will likely increase as we expand sales of our products to China, Europe and the Caribbean in the future.  We are likely to incur additional research and development expenses in fiscal year 2011 if we apply to the FDA for our U.S. clinical study protocols. There is no assurance that we will ever be profitable.
 17
 Table of Contents
  SUNRIDGE INTERNATIONAL, INC.
 Liquidity and Capital Resources
 We suffered a severe liquidity shortage in fiscal years 2009 and 2010. From July 1, 2010 to September 30, 2010, we borrowed a total of $46,133.  These loans bear annual interest of 10% to 12% and all of the loans are due on demand or prior to June 30, 2011.  During the quarter ended September 30, 2010 our interest expense increased by 37.0% ($5,613) in comparison to the quarter ended September 30, 2009 as a result of increased borrowings during the prior year. During July, August and September, 2010, we paid approximately $115,050 of debt, interest and services by issuing common stock.
  As of September 30, 2010, G. Richard Smith, the Company’s President and a Director, loaned the Company an additional $21,146 and was repaid $29,917.  This debt bears an interest rate of 10% for the term, and 12% per annum thereafter, and is due on demand.  At September 30, 2010, G. Richard Smith was owed $195,605 by the Company.
 Without substantial funding in the very near future, our liquidity shortage will become critical.  We are hopeful we will be able to obtain substantial funding during the remainder of fiscal year 2011, but we presently have no agreements or arrangements to obtain any such funding.  (See “Part II, Item 1. Legal Proceedings” and “Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds” below.)
 Over the next three years, we must obtain at least $6,500,000 of funding to finance our two planned patient clinical studies in Canada and the U.S., and a minimum level of administrative staff. If such funding is not obtained, it is unlikely we will receive FDA approval for the sale of our product in the U.S. Without FDA approval our revenues will be totally dependent on foreign sales.
 The consolidated financial statements contained in this Form 10-Q have been prepared assuming we will continue to operate and do not include any adjustments that might be necessary if we are unable to continue as a going concern. As a result, our independent registered public accountants have issued a going concern explanatory paragraph to their audit report on our consolidated financial statements for the fiscal year ended June 30, 2010, and that qualification would have been extended through the quarter ended September 30, 2010.


Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
 Not applicable.
 18
 Table of Contents
 SUNRIDGE INTERNATIONAL, INC.
 Item 4.
Controls and Procedures.
 Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures
 Under the supervision and with the participation of our principal executive officer and principal financial officer, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the Exchange Act). Accordingly, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures as defined in Rule 13a-15(e) under the Exchange Act were not effective as of September 30, 2010 to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is recorded, processed, and summarized and reported within the time periods specified in SEC rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions as appropriate to allow timely decisions regarding required disclosure.
 Management conducted a thorough review of all significant or non-routine adjustments for the quarter ended September 30, 2010. As a result of this review, management believes that there are no material inaccuracies or omissions of material fact and, to the best of their knowledge, believes that the unaudited consolidated financial statements for the quarter ended September 30, 2010 fairly present in all material respects the financial condition and results of operations for the Company in conformity with U.S. generally accepted accounting principles.
  Inherent Limitations Over Internal Controls
  Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations, including the possibility of human error and circumvention by collusion or overriding of controls. Accordingly, even an effective internal control system may not prevent or detect material misstatements on a timely basis. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.
  Changes in Internal Control Over Financial Reporting.
  We have made no change in our internal control over financial reporting during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 19
 Table of Contents
 SUNRIDGE INTERNATIONAL, INC.


PART II.
OTHER INFORMATION
 Item 1.
Legal Proceedings.
  In January 2010, we commenced negotiations with certain creditors for the repayment of their entire debt during 2010, based upon expected financing during 2010. There is no assurance our efforts to negotiate with our creditors will be resolved without litigation.
 On December 16, 2009, our patent attorneys, Meschkow & Gresham, P.L.C., filed a lawsuit (CV 2009-037698) in the Superior Court for Maricopa County, Arizona against the Company and Mr. Richard Smith for breach of contract in the failure to pay for legal services in the amount of $12,063 plus costs and legal fees. Our answer to the complaint admitted that legal services had been provided but claimed no knowledge of the value of those services. This case was transferred to arbitration and an award was rendered in the amount of $8,064 against G. Richard Smith, our President and Director, his wife, Karen Smith and the Ophthalmic International, Inc., our wholly-owned subsidiary, plus court costs of $453 and attorney fees of $1,500.  This arbitration award has not been filed with the Clerk of the Court to proceed to judgment yet.
 
 During our fourth quarter 2010, Charles E. Brokup filed a lawsuit (CV 2010-054295) in Superior Court for Maricopa County, Arizona against Ophthalmic International, Inc. and Mr. G. Richard Smith for breach of promise to pay $10,000 principal on a promissory note and $1,000 per month in interest. Our answer to the complaint admitted that the principal amount of $10,000 was owed but denies that more than legal interest is owed after the first month expressly stated interest of $1,000.
  During the quarter ended September 30, 2010, Francesco Aspes, our former European marketing consultant, filed a lawsuit (CV 2010-028530) in the Superior Court for Maricopa County, Arizona against the Company for failure to pay him $180,000 of employee wages earned previously plus 80,000 Euros of expenses incurred as an employee of the Company. Our answer to this complaint has not yet been filed.
 Other than as set forth above, the Company is not currently a party to any pending lawsuit or legal proceeding.
 Item 1A.
Risk Factors.
 Not applicable.
 Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
 Between July 1, 2010 and September 30, 2010, the Company issued the following restricted common stock: (i) 45,161 shares for $8,300 of services by one Non-Accredited Investor, as defined by SEC Rule 501; (ii) 302,058 shares in conversion of $59,750 of debt and accrued interest by four Non-Accredited Investors; (iii) 200,000 shares for $47,000 of public relations services by two Non-Accredited firms; and (iv) 100,000 shares to one Non-Accredited Investor for $17,000 cash. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.
 20
 Table of Contents
  SUNRIDGE INTERNATIONAL, INC.
 Subsequent Events
  Between October 1, 2010 and November 11, 2010, the Company issued the following restricted common stock: (i) 60,417 shares for $8,500 of services by one Non-Accredited Investor, as defined by SEC Rule 501; (ii) 130,000 shares in conversion of $13,000 of debt and accrued interest by three Non-Accredited Investors; (iii) 200,000 shares for $22,000 of public relations services by one Non-Accredited firm; (iv) 790,909 shares to three Non-Accredited Investors for $34,000 cash; and (v) 259,091 shares for $27,500 of consulting services by two Non-Accredited Investors. These sales were made without public solicitation. There were no underwriting discounts or commissions paid on these sales of securities.
 Item 3.
Defaults Upon Senior Securities.
  None.
  Item 4.
(Removed and Reserved).
 
 Item 5.
Other Information.
 None.
 Item 6.
Exhibits


Exhibit No.

Description31.1*

Certification by Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act *31.2*

Certification by Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act *32.1*

Certification by Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act *32.2*

Certification by Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act *
  *
Filed herewith.
 21
 Table of Contents
 SUNRIDGE INTERNATIONAL, INC.
 Signatures
  Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


SUNRIDGE INTERNATIONAL, INC.Dated:   November 22, 2010
By:
/s/  G. Richard SmithG. Richard Smith

President andChief Executive Officer

(Principal Executive Officer)
 Dated:   November 22, 2010
By:
/s/  Gary R. SmithGaryR. Smith

Secretary/Treasurer,

Chief Financial Officer and Director

(Principal Accounting Officer)
 22